Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod in Active Lupus Nephritis
NCT01085097Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of laquinimod in lupus nephritis (LN), sponsored by Teva Pharmaceutical Industries Ltd.. Started Sep 2010; status: completed.
02
Drugs
laquinimod
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01085097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085097.